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The era of whole genome sequencing has now firmly entered a new phase
with the establishment of several technologies for deep or high-throughput
sequencing. Consequently, we are now moving away from generating
essentially finished, high quality reference genomes to functional genomics
and the analysis of the phenotypic impact of genetic variation in populations.
These changes are being felt in both the prokaryotic and eukaryotic worlds
with consortia getting together to work on different large-scale projects.
Examples include the sequencing of thousands of human genomes, which
are being used to identify genes associated with classical phenotypes or
disease. The analysis of the mouse is leading to large-scale gene knock-out
programmes that eventually will cover all genes. The zebrafish genome will
eventually direct similar gene knock-out programmes. In the case of bacteria
(and viruses), which have relatively small genomes, the impact is being felt
in multiple areas ranging from the analysis of RNA populations through to
the molecular definition of phylogeny. A previous issue of Current Opinion
in Microbiology (edited by Carmen Buchrieser and Stewart Cole) provided
an editorial overview and several excellent reviews that reported on this field
and here we extend the review coverage into other areas.
The era of genomics started with the generation of high quality reference
genomes that provided a blueprint for the future genetic analysis of any
species for which such a reference was available. In the case of bacteria it has
been possible to generate truly finished genomes where every base pair in a
genome (normally a circular chromosome and plasmids) is accounted for.
Such genomes can be annotated to define genes and provide functional
information or predictions of function for the investigator. Working from
such a blueprint it is possible to embark on functional studies using site-
directed mutagenesis, the analysis of RNA populations, the definition of the
proteome and to some extent themetabolome. Such analysis can be fed back
through curation to improve the annotation of the reference genome.
Researchers have embraced these possibilities in the form of functional
genomic experiments. RNA sequencing (RNA-seq) can be used to define
the transcriptome to a level not achievable with microarrays and mass
spectrometry can be used to define the peptides (and other metabolites)
expressed from these RNAs or produced during growth. Sequencing has also
been used to improve the definition of genome-wide mutagenesis exper-
iments, mapping mutagenic inserts back to specific sequences in the
genome at scale [1]. Simple machines are under development to undertake
larger scale phenotyping experiments such as Biolog (www.biolog.com),
which is used to analyse the metabolic capabilities of bacteria or automated
FACS/Image analysers, which can analyse host pathogen interactions at a
cellular level at close to high-throughput levels. Thus, the links between
gene and function are being mapped through large-scale phenotyping
projects exploiting reference genomes.
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is now possible to capture the nature of genetic variation
in great detail. This variation (SNPs, indels, mobile
elements, etc.) can be used to build phylogeny and
identify the emergence of novel variants [2]. The ability
to work at a population level means that genetic exper-
iments linking genotype to phenotype can now be under-
taken using real sample sets obtained from the field. This
has long been undertaken in human genetics through so-
called association studies but even here the approaches
will become more refined as more complete human
sequences become available rather than SNP maps.
The era of linking genotype to phenotype in microbial
pathogens is now upon us. Some of the first studies are
mapping the emergence of phenotypes, such as antibiotic
resistance, onto population structures and other pheno-
types are likely to be studied in the future including
virulence [3]. Phylogeny can also be exploited in the field.
A genome sequence provides the ultimate genetic defi-
nition (typing) of a microbe and points of variation in
closely related isolates, linked to phylogeny, can be used
in the field to map pathogen transmission with higher
resolution than sub-genomic or phenotypic approaches.
Thus, studies on microbial populations are influencing
clinical microbiology and moving studies from the labora-
tory into the field in real terms.
Croucher and Thomson provide an overview of the
current methods available to exploit Illumina platforms
and other forms of deep sequencing to analyse RNA
populations (so-called RNA-seq). Transcriptome analysis
was originally transformed by the exploitation of micro-
array technology using arrays based on whole or partial
genome sequences. The resolution of microarrays was
enhanced by the use of tiling arrays which covered every
base pair in a genome but RNA-seq provides a flexible,
labour-saving and cost-effective approach to RNA
analysis. Deep sequencing is essentially used to pile
and map sequence transcripts generated from copied
RNA back onto reference genome to the level of base
pair resolution. RNA-seq can be used in a strand-specific
manner to map overlapping transcripts read from opposite
DNA strands, further improving the level of resolution. A
significant number of papers have now been published
describing the exploitation of various RNA-seq
approaches to study microbes. Thus, a review of this
novel but important area is timely. RNA sequencing
can be linked to bioinformatic genome browsing tools
to facilitate mapping and simplify viewing of the data,
provided a rounded programme for the investigator.
The editors believe genomics is likely to have further
significant impact in the area of clinical microbiology and
thus four reviews are included that cover this important
area. Pallen and colleagues provide a compelling argu-
ment in support of this view covering a number of areas
where they feel deep sequencing will impact in the clinic.www.sciencedirect.comThey describe in practical terms some of the challenges
faced by the clinical community to adapt to genotypic
data when they have been trained to exploit phenotyping
(serotyping, biotyping, etc.) for clinical microbial analysis.
They emphasise the potential accuracy and resolving
power provided by deep genome sequence using
examples of where and how DNA sequences have been
used to tackle previously intractable problems. Whole
genome sequences provide the ultimate resolving power
for discriminating between closely related clinical iso-
lates. Indeed, the genome sequence is the ultimate typing
method and potentially the limit of resolution. They not
only discuss how DNA sequencing could be potentially
used to replace classical microbial culture techniques
through sensitive genome amplification linked to sequen-
cing but also point out where challenges remain. They
touch upon the concept of pathogen discovery through
deep sequence and link this to the ability to diagnose
disease through DNA analysis.
Palmer and colleagues use genomic and genetic analysis
of the Enterococci to beautifully illustrate how antibiotic
usage has driven the recent evolution of commensal
bacteria and how this has generated a new range of
opportunistic pathogens. The Enterococci are commen-
sal bacteria that form part of the healthy microbial
community present on humans and other animals. Nor-
mally they are harmless but the intensive use of anti-
biotics has created new and evolved forms of these
microbes with increased pathogenic potential. What is
clear is that the selection of highly mobile genetic
elements encoding resistance and other traits has been
responsible to a significant extent for this evolution.
They describe families of plasmids and transposons that
have moved into the Enterococci, creating these new
forms that harbour multiple such elements. Certain
plasmid and transposon classes appear to have adapted
to become established and inherited components of the
genome without adversely impacting fitness. Further,
such resistant Enterococci are now potentially acting as a
reservoir in humans for the dissemination of resistance
genes to human pathogens such as the Staphylococci.
They also describe some of the elements, such as
CRISPR, that are exploited by the Enterococci to con-
trol the movement and horizontal acquisition of mobile
elements.
Baker and colleagues provide a review describing how
deep sequencing can be used to resolve the population
of highly conserved (so-called monophyletic) and
recently evolved pathogens. Many well-known patho-
gens such as Salmonella typhi (the cause of typhoid) and
Yersina pestis (the cause of bubonic plague) have adapted
to infect humans relatively recently (within the last few
hundred or thousand years). Individual isolates of such
pathogens are genetically highly conserved and it was
previously very difficult to discriminate between them.Current Opinion in Microbiology 2010, 13:616–618
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brought to bear on some of these pathogenic agents
allowing isolates to be distinguished through rare points
of genome variation (often SNPs) and facilitate the
building of phylogenetic information. In the review
the authors describe how with some pathogens such
as S. typhi they can now discriminate between isolates in
the field and potentially build transmission maps. Such
maps can be built in real geographical space by exploit-
ing computer software such as Google Earth covering
specific locations such as cities. The work in this area is
rapidly evolving and the reviewers describe some of the
very latest developments.
Cholera is one of the classical infection scourges of
humankind and is still a very common disease in many
parts of the developing world. The disease is caused by
toxigenic variants of Vibrio cholerae O1. A series of world-
wide pandemics of cholera have been described through-
out history with the latest (the so-called seventh
pandemic) still raging. Classical microbial studies have
thrown some light on the emergence of cholera pan-
demics. Isolates are known to evolve certain phenotypic
characteristics as the pandemic progresses but this has not
previously been put into a genome context. Cho et al.
have been involved in some of the first applications of
deep sequencing to V. cholerae and they provide novel and
fascinating insights into the evolution of this pathogen.
They provide evidence that the current pandemic is
caused by a highly related clone which has been disse-
minated at a global scale. They describe the ‘mobilome’
of this pathogen, composed of multiple mobile elements
that have moved into and out of the species through time.
They describe the genetic basis of some of the previously
recognised phenotypic changes recorded in V. cholerae
during the seventh pandemic.Current Opinion in Microbiology 2010, 13:616–618In the final reviewWorden and Allen turn our attention to
eukaryotic microbes, focusing on marine protists, where
genomics is penetrating into many previously poorly
understood areas. The phylogeny of eukaryotic microbes
is still being assembled and encompasses vast diversity
but genomics is providing a major approach to elucidating
new lineages. This is made particularly challenging by the
composite structure of these genomes, with genes from
other eukaryotic lineages and prokaryotic remnants. Mar-
ine protists are also members of complex communities
and metagenomic methods are needed for adequate
sampling as well as addressing the many uncultured
organisms. These approaches also identify an extensive
gene and pathway content of the communities, which is
essential for understanding their impact on the environ-
ment. Thus from evolutionary, environmental, ecological,
and model system perspectives, the genomics of eukar-
yotic microbes is a young but vigorous field.
These articles then represent a few examples of the new
genomics, enlivened by next generation sequencing tech-
nology, which has allowed the field to penetrate deeper
into the biology of individual organisms as well as com-
munities and populations.Microbial genomics is alive and
well, with an exciting future.
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